B-412 A novel approach to detect synthetic urine simultaneously with drug confirmation by LC-MS/MS

IF 8.3 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY
Rojeet Shrestha, Kascion Outland, Binata Shrestha, Safedin Beqaj
{"title":"B-412 A novel approach to detect synthetic urine simultaneously with drug confirmation by LC-MS/MS","authors":"Rojeet Shrestha, Kascion Outland, Binata Shrestha, Safedin Beqaj","doi":"10.1093/clinchem/hvag086.679","DOIUrl":null,"url":null,"abstract":"Background The widespread availability of affordable synthetic urine in the market that can pass traditional specimen validity criteria has been a rising issue of concern in recent days. These synthetic products visually appear natural and possess normal creatinine, pH, specific gravity, urea, uric acid, and urobilinogen. Many of these products has artificial urinator that can be wrapped on the waist and has heat activators to mimic physiological temperature. Therefore, current specimen validity criteria are ineffective for detecting these synthetic urines needing novel approach. Methods We developed a tandem mass spectrometric assay for the simultaneous quantification of metabolites of catecholamines in urine along with drug confirmation. The presence of these substances in urine is a strong indicator of urine from biological sources and can be potentially used to differentiate fake synthetic urine. An algorithm based on the metabolites of catecholamines are used to identify synthetic urine (gnosis verified). A total of 12 different commercially available synthetic urine was evaluated to determine its efficiency along with 230 healthy human urine samples. Results All tested commercial synthetic urine pass conventional validity test including creatinine, pH and specific gravity but failed for gnosis verified while all samples from healthy urine sample passed. We identified a total of 54 synthetic urine over a period of year of which 30 samples were negative for all tested drugs including cotinine. Remaining samples were positive for various drugs including alprazolam, buprenorphine, oxycodone and hydrocodone apparently spiked directly into the synthetic urine as indicated by absence of metabolites. Conclusion Simultaneous identification of synthetic urine in LC-MS/MS run of drug confirmation is cost-effective, efficient and novel approach to detect adulteration of sample. Presence of metabolites of catecholamine in urine is a strong indicator of urine from biological source and can be potentially used to differentiate fake synthetic urine.","PeriodicalId":10690,"journal":{"name":"Clinical chemistry","volume":"53 1","pages":""},"PeriodicalIF":8.3000,"publicationDate":"2026-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/clinchem/hvag086.679","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background The widespread availability of affordable synthetic urine in the market that can pass traditional specimen validity criteria has been a rising issue of concern in recent days. These synthetic products visually appear natural and possess normal creatinine, pH, specific gravity, urea, uric acid, and urobilinogen. Many of these products has artificial urinator that can be wrapped on the waist and has heat activators to mimic physiological temperature. Therefore, current specimen validity criteria are ineffective for detecting these synthetic urines needing novel approach. Methods We developed a tandem mass spectrometric assay for the simultaneous quantification of metabolites of catecholamines in urine along with drug confirmation. The presence of these substances in urine is a strong indicator of urine from biological sources and can be potentially used to differentiate fake synthetic urine. An algorithm based on the metabolites of catecholamines are used to identify synthetic urine (gnosis verified). A total of 12 different commercially available synthetic urine was evaluated to determine its efficiency along with 230 healthy human urine samples. Results All tested commercial synthetic urine pass conventional validity test including creatinine, pH and specific gravity but failed for gnosis verified while all samples from healthy urine sample passed. We identified a total of 54 synthetic urine over a period of year of which 30 samples were negative for all tested drugs including cotinine. Remaining samples were positive for various drugs including alprazolam, buprenorphine, oxycodone and hydrocodone apparently spiked directly into the synthetic urine as indicated by absence of metabolites. Conclusion Simultaneous identification of synthetic urine in LC-MS/MS run of drug confirmation is cost-effective, efficient and novel approach to detect adulteration of sample. Presence of metabolites of catecholamine in urine is a strong indicator of urine from biological source and can be potentially used to differentiate fake synthetic urine.
LC-MS/MS同时检测合成尿的新方法
近年来,市场上普遍存在可负担得起的合成尿液,这些尿液可以通过传统的标本有效性标准,这已成为人们日益关注的问题。这些合成产品在视觉上看起来是天然的,具有正常的肌酐、pH值、比重、尿素、尿酸和尿胆素原。许多这类产品都有人工排尿器,可以包在腰上,并有热激活器来模拟生理温度。因此,目前的标本效度标准对于检测这些合成尿液是无效的,需要新的方法。方法建立串联质谱法,同时定量测定尿中儿茶酚胺代谢物并进行药物确证。尿液中这些物质的存在是生物来源尿液的一个强有力的指标,可以潜在地用于区分假合成尿液。基于儿茶酚胺代谢物的算法用于识别合成尿(诊断验证)。总共评估了12种不同的市售合成尿液,以确定其效率以及230个健康人类尿液样本。结果所有商品合成尿均通过肌酐、pH、比重等常规效度测试,但未通过诊断验证,而健康尿液均通过诊断验证。在过去的一年中,我们共鉴定出54份合成尿液,其中30份样本对包括可替宁在内的所有测试药物均呈阴性。剩余的样品中各种药物呈阳性,包括阿普唑仑、丁丙诺啡、羟考酮和氢可酮,由于没有代谢物,显然直接添加到合成尿液中。结论在药物确证的LC-MS/MS运行中同时检测合成尿是一种成本低、效率高、检测样品掺假的新方法。尿液中儿茶酚胺代谢物的存在是尿液生物来源的一个强有力的指标,可以潜在地用于区分假合成尿。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical chemistry
Clinical chemistry 医学-医学实验技术
CiteScore
11.30
自引率
4.30%
发文量
212
审稿时长
1.7 months
期刊介绍: Clinical Chemistry is a peer-reviewed scientific journal that is the premier publication for the science and practice of clinical laboratory medicine. It was established in 1955 and is associated with the Association for Diagnostics & Laboratory Medicine (ADLM). The journal focuses on laboratory diagnosis and management of patients, and has expanded to include other clinical laboratory disciplines such as genomics, hematology, microbiology, and toxicology. It also publishes articles relevant to clinical specialties including cardiology, endocrinology, gastroenterology, genetics, immunology, infectious diseases, maternal-fetal medicine, neurology, nutrition, oncology, and pediatrics. In addition to original research, editorials, and reviews, Clinical Chemistry features recurring sections such as clinical case studies, perspectives, podcasts, and Q&A articles. It has the highest impact factor among journals of clinical chemistry, laboratory medicine, pathology, analytical chemistry, transfusion medicine, and clinical microbiology. The journal is indexed in databases such as MEDLINE and Web of Science.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书